Thymic small cell carcinoma shows marked response to amrubicin.
Igawa
Satoshi
S
Murakami
Haruyasu
H
Yamamoto
Nobuyuki
N
D018943:Anthracyclines / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D018288:Carcinoma, Small Cell / Q000188:drug therapy* / Q000556:secondary; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000556:secondary; D008297:Male; D008875:Middle Aged; D010997:Pleural Neoplasms / Q000188:drug therapy / Q000556:secondary; D016879:Salvage Therapy; D013953:Thymus Neoplasms / Q000188:drug therapy* / Q000473:pathology
D018943:Anthracyclines; D000970:Antineoplastic Agents; C055866:amrubicin